Nucleic Health Innovations Profile
Key Indicators
- Authorised Capital ₹ 4.75 Cr
- Paid Up Capital ₹ 2.78 Cr
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.93 Cr
- Revenue Growth -1.48%
- Profit Growth -17.00%
- Ebitda 33.55%
- Net Worth 43.97%
- Total Assets -12.79%
About Nucleic Health Innovations
Nucleic Health Innovations Private Limited (NHIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 February 2017 (Seven years and 11 months 24 days old ). Its registered office is in Ernakulam, Kerala, India.
The Corporate was formerly known as Nucleic Imaging Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.75 Cr and a paid-up capital of Rs 2.78 Cr.
The company currently has active open charges totaling ₹5.93 Cr.
Jiji Mathew, Augustus Joseph, Jophy Jose, and One other member serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999KL2017PTC048202
-
Company No.
048202
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Feb 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Nucleic Health Innovations?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jiji Mathew
|
Director | 09-Feb-2017 | Current |
|
Augustus Joseph
|
Director | 10-Jul-2017 | Current |
|
Jophy Jose
|
Director | 12-Aug-2017 | Current |
|
Leona Fernandez
|
Whole-Time Director | 18-Aug-2023 | Current |
Financial Performance of Nucleic Health Innovations.
Nucleic Health Innovations Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.48% decrease. The company also saw a substantial fall in profitability, with a 17% decrease in profit. The company's net worth Soared by an impressive increase of 43.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nucleic Health Innovations?
Unlock access to Nucleic Health Innovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tecforz Innovations Private LimitedJiji Mathew and Jophy Jose are mutual person
Charges (Loans)
₹5.93 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 5.71 Cr
- Canara Bank : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2020 | Canara Bank | ₹2.15 M | Open |
| 19 Sep 2017 | State Bank Of India | ₹5.71 Cr | Open |
How Many Employees Work at Nucleic Health Innovations?
Nucleic Health Innovations has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleic Health Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleic Health Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
